In the CTC oncology trials program our focus is to provide innovative clinical research to inform clinical practice, improve health outcomes and save lives in the expert areas of breast, gastro-intestinal, lung, gynaecological, neurological and urogenital cancers.
The CTC works collaboratively with five of the 13 national cancer cooperative groups to design and run clinical trials. We are a leader in developing and conducting novel trial designs, including adaptive designs and genomics-driven screening. We have collaborated in over 180 projects, which thousands of patients have joined.
The CTC is the coordinating centre for the:
The CTC also supports the statistical activities of the Australia and New Zealand Breast Cancer Trials Group (BCT) and the Primary Care Collaborative Cancer Clinical Trials Group (PC4).
The CTC covers the full range of responsibilities involved in conducting clinical trials — from assisting in establishing new groups by creating a research governance structure and terms of reference, identifying important questions related to public health, through to large-scale trial operations in collaboration with research groups. These include concept and protocol development, randomisation, data collection, ethics and regulatory compliance, on-site monitoring and audit, and data analyses and manuscript preparation.
For more information, contact our CTC Oncology Co-directors, John Simes or Martin Stockler.
